CWC
DXCM icon

Carolinas Wealth Consulting’s DexCom DXCM Stock Holding History

Carolinas Wealth Consulting’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15
Closed -$1.02K – 248
2025
Q1 		$1.02K Sell
15
-1
-6% -$82 ﹤0.01% 903
2024
Q4 		$1.25K Sell
16
-4
-20% -$296 ﹤0.01% 909
2024
Q3 		$1.34K Buy
20
+10
+100% +$821 ﹤0.01% 879
2024
Q2 		$1.13K Sell
10
-4
-29% -$506 ﹤0.01% 891
2024
Q1 		$1.94K Sell
14
-361
-96% -$45.4K ﹤0.01% 798
2023
Q4 		$46.5K Hold
375
– – 0.01% 347
2023
Q3 		$33.3K Buy
375
+350
+1,400% +$39.5K 0.01% 362
2023
Q2 		$3.24K Sell
25
-1
-4% -$121 ﹤0.01% 747
2023
Q1 		$3.02K Sell
26
-3
-10% -$336 ﹤0.01% 765
2022
Q4 		$3.28K Buy
29
+20
+222% +$2.2K ﹤0.01% 748
2022
Q3 		$1K Buy
+9
New +$762 ﹤0.01% 806
2022
Q2 		– Sell
-8
Closed -$1K – 900
2022
Q1 		$1K Hold
8
– – ﹤0.01% 836
2021
Q4 		$1K Hold
8
– – ﹤0.01% 870
2021
Q3 		$1K Hold
8
– – ﹤0.01% 846
2021
Q2 		$1K Buy
+8
New +$768 ﹤0.01% 857

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Carolinas Wealth Consulting's DXCM Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of DexCom (DXCM) in Q2 2025, closing a stake of 15 shares — an estimated $1.02K sold.

Carolinas Wealth Consulting first reported a position in DXCM in Q2 2021 and held it in 15 quarters. The position peaked at $46.5K in Q4 2023. 940 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 15 DexCom shares in Q2 2025, an estimated $1.02K.
  • Carolinas Wealth Consulting first reported a position in DexCom in Q2 2021 and held it in 15 quarters.
  • Carolinas Wealth Consulting's DexCom position peaked at $46.5K in Q4 2023.
  • 940 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.